Hepatitis
News
HCV coinfection adds to cardiovascular risk in HIV-infected patients
News
Statins hamper hepatocellular carcinoma in viral hepatitis patients
Two years of daily lipophilic statin use was associated with lower incidence of HCC and reduced all-cause death and liver-related death, compared...
News
HCV-infected people who inject drugs also have substantial alcohol use
News
USPSTF updates, reaffirms recommendation for HBV screening in pregnant women
There have been improvements in maternal HBV therapy since the original 2009 USPSTF recommendation.
News
HCC surveillance after anti-HCV therapy cost effective only for patients with cirrhosis
Surveillance twice a year of all patients with F3 or F4 fibrosis had a less than 1% chance of remaining under a $50,000 per QALY willingness-to-...
News
Despite HCV cure, liver cancer-associated genetic changes persist
News
DOPPS participation associated with lower HCV rates in dialysis patients
HCV infection decreased from 2.9 to 1.2 per 100 patient-years in countries participating in the initial phase of DOPPS.
News
AGA Clinical Practice Update: Direct-acting antivirals and hepatocellular carcinoma
For patients listed for liver transplantation, determine timing of DAA therapy on a case-by-case basis, consider regional wait times, availability...
Conference Coverage
Ribavirin boosts HCV genotype 3 eradication in compensated cirrhotic patients
VIENNA – Data from more than 14,000 English patients showed incremental benefit from ribavirin when treating hepatitis C genotype 3 virus.
News
Mavyret approved for children with any HCV genotype
Mavyret (glecaprevir and pibrentasvir) tablets are the first means of treating any of six identified genotypes of HCV in children.